The top VCs in healthcare have played an active role in shaping emerging fields in cancer therapeutics.
Using the CB Insights platform, we compiled a list of 27 investors that, according to portfolio strength and exit history, are the best-performing VCs in healthcare.
Since reaching its peak in 2015 with 51 deals, smart money VCs’ participation in cancer therapeutics has been slowing down, evidenced by two consecutive years of decreasing investments in this space.
Image: https://www.cbinsights.com
